Photo taken from ESMO/LinkedIn
Jul 6, 2024, 13:29
ESMO – immune cell-related biomarkers in metastatic HNSCC
ESMO shared on LinkedIn:
“Latest podcast. Annals of Oncology Editor in Chief Tom Powles talks to Amanda Psyrri. They discuss her recently published study that aimed to investigate the association of immune cell-related biomarkers in the tumor and tumor microenvironment with PD-1 checkpoint inhibitors’ outcomes in patients with metastatic head and neck squamous cell cancer (HNSCC).”
Read further.
Source: ESMO/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 09:22
Dec 21, 2024, 09:06
Dec 21, 2024, 09:00
Dec 21, 2024, 08:51
Dec 21, 2024, 08:48
Dec 21, 2024, 08:42
Dec 21, 2024, 08:37
Dec 21, 2024, 08:29
Dec 21, 2024, 08:12